CHARLES FLEVENBACKCHARLES F LEVENBACK8444LEVENBACK, CHARLES FProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25365592Prescott LS, Kidin LM, Downs RL, Cleveland DJ, Wilson GL, Munsell MF, DeJesus AY, Cain KE, Ramirez PT, Kroll MH, Levenback CF, Schmeler KMInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyImproved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence. Int J Gynecol Cancer. 2015 Jan; 25(1):152-9.Int J Gynecol Cancer2015-01-01T00:00:002015Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.1400 Pressler StHouston77030-4008TXAuthorship 1631831Authorship 1651421Authorship 1652974Authorship 1660832Authorship 1672052Authorship 1683615Authorship 169917Authorship 1700903Authorship 1709549Authorship 171838Authorship 1727472Authorship 1731297Authorship 1735614Authorship 1741893Authorship 1743783Authorship 1747467Authorship 1751679Authorship 1752283Authorship 1753208Authorship 1754082Authorship 1757677Authorship 1762523Authorship 1764611Authorship 1765199Authorship 1772075Authorship 1778436Authorship 1778578Authorship 1779077Authorship 1784383Authorship 1785114Authorship 1797912Authorship 1800673Authorship 1803454Authorship 1804426Authorship 1812032Authorship 1814841Authorship 1816887Authorship 1823876Authorship 1838372Authorship 1848684Authorship 1850908Authorship 1851914Authorship 1857137Authorship 1862645Authorship 1878637Authorship 1886139Authorship 1900779Authorship 1904635Authorship 1904828Authorship 1905804Authorship 1910677Authorship 19173211Authorship 19312851592288Levenback C, Rubin SC, McCormack PM, Hoskins WJ, Atkinson EN, Lewis JLGynecologic oncologyResection of pulmonary metastases from uterine sarcomas. Gynecol Oncol. 1992 May; 45(2):202-5.Gynecol Oncol1992-05-01T00:00:001992Resection of pulmonary metastases from uterine sarcomas.7729738Burke TW, Morris M, Roh MS, Levenback C, Gershenson DMGynecologic oncologyPerineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol. 1995 May; 57(2):221-5.Gynecol Oncol1995-05-01T00:00:001995Perineal reconstruction using single gracilis myocutaneous flaps.8022455Zimecki MWThe New England journal of medicine. . . and how the decisions are made. N Engl J Med. 1994 Aug 04; 331(5):331; author reply 332.N Engl J Med1994-08-04T00:00:001994. . . and how the decisions are made.8557227Segreti EM, Levenback C, Morris M, Lucas KR, Gershenson DM, Burke TWGynecologic oncologyA comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas. Gynecol Oncol. 1996 Jan; 60(1):49-53.Gynecol Oncol1996-01-01T00:00:001996A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas.9083300Morris M, Levenback C, Burke TW, Dejesus Y, Lucas KR, Gershenson DMObstetrics and gynecologyAn outcomes management program in gynecologic oncology. Obstet Gynecol. 1997 Apr; 89(4):485-92.Obstet Gynecol1997-04-01T00:00:001997An outcomes management program in gynecologic oncology.10202164Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DGThe New England journal of medicinePelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999 Apr 15; 340(15):1137-43.N Engl J Med1999-04-15T00:00:001999Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.11354055Muderspach LI, Blessing JA, Levenback C, Moore JLGynecologic oncologyA Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 2001 May; 81(2):213-5.Gynecol Oncol2001-05-01T00:00:002001A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.12011139Barranger E, Grahek D, Cortez A, Uzan S, Darai EJournal of clinical oncology : official journal of the American Society of Clinical OncologyLaparoscopic sentinel node procedure in patients with cervical cancer. J Clin Oncol. 2002 May 15; 20(10):2602-3; author reply 2603.J Clin Oncol2002-05-15T00:00:002002Laparoscopic sentinel node procedure in patients with cervical cancer.14529679Ramirez PT, Wolf JK, Levenback CGynecologic oncologyLaparoscopic port-site metastases: etiology and prevention. Gynecol Oncol. 2003 Oct; 91(1):179-89.Gynecol Oncol2003-10-01T00:00:002003Laparoscopic port-site metastases: etiology and prevention.14751187Donato ML, Levenback C, Gershenson DM, McMeekin S, Champlin REGynecologic oncologyMatched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report. Gynecol Oncol. 2004 Jan; 92(1):365-7.Gynecol Oncol2004-01-01T00:00:002004Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.15050345van der Velden J, Ansink AInternational journal of radiation oncology, biology, physicsIn regards to Katz et al.: The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva (Int J Radiat Oncol Biol Phys 2003;57:409-418). Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1635; author reply 1635-6.Int J Radiat Oncol Biol Phys2004-04-01T00:00:002004In regards to Katz et al.: The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva (Int J Radiat Oncol Biol Phys 2003;57:409-418).15304150Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback CInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyApproaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer. 2004 Jul-Aug; 14(4):580-8.Int J Gynecol Cancer2004-07-01T00:00:002004Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study.15361188Tangjitgamol S, See HT, Manusirivithaya S, Levenback CF, Gershenson DM, Kavanagh JJInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyThird-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients. Int J Gynecol Cancer. 2004 Sep-Oct; 14(5):804-14.Int J Gynecol Cancer2004-09-01T00:00:002004Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients.15882895Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback CGynecologic oncologyPhase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4.Gynecol Oncol2005-06-01T00:00:002005Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.16209083Levenback CCancer treatment and researchSelective sentinel lymphadenectomy for gynecologic cancer. Cancer Treat Res. 2005; 127:167-85.Cancer Treat Res2005-01-01T00:00:002005Selective sentinel lymphadenectomy for gynecologic cancer.16271384Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DMGynecologic oncologyPhase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol. 2006 Apr; 101(1):126-31.Gynecol Oncol2005-11-03T00:00:002005Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.17292461Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, Gershenson DMGynecologic oncologyLack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Gynecol Oncol. 2007 May; 105(2):404-8.Gynecol Oncol2007-02-09T00:00:002007Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary.17398031Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven KInternational journal of radiation oncology, biology, physicsExtended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1081-7.Int J Radiat Oncol Biol Phys2007-03-29T00:00:002007Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.17869451Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJInternational journal of radiation oncology, biology, physicsComparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):118-25.Int J Radiat Oncol Biol Phys2007-09-14T00:00:002007Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.19457548Levenback CF, van der Zee AG, Rob L, Plante M, Covens A, Schneider A, Coleman R, Solima E, Hertel H, Barranger E, Obermair A, Roy MGynecologic oncologySentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol. 2009 Aug; 114(2):151-6.Gynecol Oncol2009-08-01T00:00:002009Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008.20222977Kavanagh JJ, Levenback CF, Ramirez PT, Wolf JL, Moore CL, Jones MR, Meng L, Brown GL, Bast RCJournal of hematology & oncologyPhase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer. J Hematol Oncol. 2010 Mar 11; 3:9.J Hematol Oncol2010-03-11T00:00:002010Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer.Gynecological Oncology & Reproductive MedicineMD Anderson5.425630.00315963480research areas4.837140.011579388coauthor of193.83822.077760similar to11219selected publicationsPEDRO TOMASRAMIREZPEDRO TOMAS RAMIREZ8779RAMIREZ, PEDRO TOMASProfessorKELLY KHUNTKELLY K HUNT8555HUNT, KELLY KProfessorDIANE CBODURKADIANE C BODURKA8604BODURKA, DIANE CProfessorMICHAELFRUMOVITZMICHAEL FRUMOVITZ8953FRUMOVITZ, MICHAELProfessorROBERTCOLEMANROBERT COLEMAN9184COLEMAN, ROBERTProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorKATHLEEN MSCHMELERKATHLEEN M SCHMELER9171SCHMELER, KATHLEEN MAssociate ProfessorAuthorship 2121151Authorship 2140705Authorship 2146891Authorship 2147365Authorship 2149725Authorship 2150505Authorship 2152153Authorship 2152803Authorship 2153584Authorship 2154475Authorship 2155165Authorship 2155191Authorship 2157763Authorship 2158751Authorship 2159342Authorship 2159541Authorship 2167804Authorship 2169195Authorship 2175083Authorship 2183674Authorship 2188842Authorship 21892319Authorship 2190192Authorship 2209717Authorship 2210953Authorship 2212284Authorship 2223345Authorship 2242735Authorship 2251091Authorship 2255989Authorship 2263827Authorship 2282344Authorship 2283324Authorship 2315866Authorship 23220271500021Levenback C, Dershaw DD, Rubin SCGynecologic oncologyEndoluminal ultrasound staging of cervical cancer. Gynecol Oncol. 1992 Aug; 46(2):186-90.Gynecol Oncol1992-08-01T00:00:001992Endoluminal ultrasound staging of cervical cancer.7590475Sweeten KM, Gershenson DM, Burke TW, Morris M, Levenback C, Silva EGGynecologic oncologySalvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol. 1995 Nov; 59(2):211-5.Gynecol Oncol1995-11-01T00:00:001995Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC).7590477Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C, Gershenson DMGynecologic oncologySurveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995 Nov; 59(2):221-5.Gynecol Oncol1995-11-01T00:00:001995Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme.7828135McIntyre JF, Eifel PJ, Levenback C, Oswald MJCancerUreteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995 Feb 01; 75(3):836-43.Cancer1995-02-01T00:00:001995Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix.7959285Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DMGynecologic oncologyHemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10.Gynecol Oncol1994-11-01T00:00:001994Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix.8005733Umpierre SA, Burke TW, Tornos C, Ordonez N, Levenback C, Morris MInternational journal of gynecological pathology : official journal of the International Society of Gynecological PathologistsImmunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol. 1994 Apr; 13(2):127-30.Int J Gynecol Pathol1994-04-01T00:00:001994Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors.8065415Levenback CThe New England journal of medicineThe NSABP trials. N Engl J Med. 1994 Sep 22; 331(12):809.N Engl J Med1994-09-22T00:00:001994The NSABP trials.8112651Burke TW, Munkarah A, Kavanagh JJ, Morris M, Levenback C, Tornos C, Gershenson DMGynecologic oncologyTreatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400.Gynecol Oncol1993-12-01T00:00:001993Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin.8602303Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JTObstetrics and gynecologyTreatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31.Obstet Gynecol1996-04-01T00:00:001996Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.8622071Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Levenback C, Chantarawiroj P, Gonzalez de Leon C, Kim EE, Madden T, Wallin B, Hord M, Verschraegen C, Raber M, Kavanagh JJJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J Clin Oncol. 1996 May; 14(5):1552-7.J Clin Oncol1996-05-01T00:00:001996Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.8751545Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DMGynecologic oncologyIntraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996 Aug; 62(2):169-73.Gynecol Oncol1996-08-01T00:00:001996Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study.8784887Levenback CF, Tortolero-Luna G, Pandey DK, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell MObstetrics and gynecology clinics of North AmericaUterine sarcoma. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):457-73.Obstet Gynecol Clin North Am1996-06-01T00:00:001996Uterine sarcoma.8898171Segreti EM, Morris M, Levenback C, Lucas KR, Gershenson DM, Burke TWGynecologic oncologyTransverse colon urinary diversion in gynecologic oncology. Gynecol Oncol. 1996 Oct; 63(1):66-70.Gynecol Oncol1996-10-01T00:00:001996Transverse colon urinary diversion in gynecologic oncology.8995541Munkarah AR, Hallum AV, Morris M, Burke TW, Levenback C, Atkinson EN, Wharton JT, Gershenson DMGynecologic oncologyPrognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7.Gynecol Oncol1997-01-01T00:00:001997Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.8995575DiSaia PJGynecologic oncologyWhat is the proper extent of an inguinal lymphadenectomy for early vulvar cancer? Gynecol Oncol. 1997 Jan; 64(1):183-5.Gynecol Oncol1997-01-01T00:00:001997What is the proper extent of an inguinal lymphadenectomy for early vulvar cancer?9299255Griffenberg L, Morris M, Atkinson N, Levenback CGynecologic oncologyThe effect of dietary fiber on bowel function following radical hysterectomy: a randomized trial. Gynecol Oncol. 1997 Sep; 66(3):417-24.Gynecol Oncol1997-09-01T00:00:001997The effect of dietary fiber on bowel function following radical hysterectomy: a randomized trial.9508195Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, Gershenson DMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8.J Clin Oncol1998-03-01T00:00:001998Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.9790784Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman LDGynecologic oncologyA phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1998 Sep; 70(3):334-8.Gynecol Oncol1998-09-01T00:00:001998A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.10094877Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DMGynecologic oncologyRadiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41.Gynecol Oncol1999-04-01T00:00:001999Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary.10849525Donato ML, Gershenson D, Ippoliti C, Wharton JT, Bast RC, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin REBone marrow transplantationHigh-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40.Bone Marrow Transplant2000-06-01T00:00:002000High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.10926801Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JTGynecologic oncologyPosttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000 Aug; 78(2):187-93.Gynecol Oncol2000-08-01T00:00:002000Posttherapy surveillance of women with cervical cancer: an outcomes analysis.11330956Munkarah A, Levenback C, Wolf JK, Bodurka-Bevers D, Tortolero-Luna G, Morris RT, Gershenson DMGynecologic oncologySecondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol. 2001 May; 81(2):237-41.Gynecol Oncol2001-05-01T00:00:002001Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.11426977Ramirez PT, Levenback C, Burke TW, Eifel P, Wolf JK, Gershenson DMGynecologic oncologySigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5.Gynecol Oncol2001-07-01T00:00:002001Sigmoid perforation following radiation therapy in patients with cervical cancer.14668555Pongtippan A, Malpica A, Levenback C, Deavers MT, Silva EGInternational journal of gynecological pathology : official journal of the International Society of Gynecological PathologistsSkene's gland adenocarcinoma resembling prostatic adenocarcinoma. Int J Gynecol Pathol. 2004 Jan; 23(1):71-4.Int J Gynecol Pathol2004-01-01T00:00:002004Skene's gland adenocarcinoma resembling prostatic adenocarcinoma.14990643Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DGJournal of clinical oncology : official journal of the American Society of Clinical OncologyPelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004 Mar 01; 22(5):872-80.J Clin Oncol2004-03-01T00:00:002004Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.15297186Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DMGynecologic oncologyA phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol. 2004 Aug; 94(2):442-8.Gynecol Oncol2004-08-01T00:00:002004A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.16472844Ramirez PT, Slomovitz BM, Soliman PT, Coleman RL, Levenback CGynecologic oncologyTotal laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience. Gynecol Oncol. 2006 Aug; 102(2):252-5.Gynecol Oncol2006-02-10T00:00:002006Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience.17448795Levenback CFGynecologic oncologyHas the time come for sentinel lymph node biopsy alone in radical hysterectomy patients? Gynecol Oncol. 2007 May; 105(2):283-4.Gynecol Oncol2007-05-01T00:00:002007Has the time come for sentinel lymph node biopsy alone in radical hysterectomy patients?17905421Ramirez PT, Landen CN, Coleman RL, Milam MR, Levenback C, Johnston TA, Gershenson DMGynecologic oncologyPhase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):68-71.Gynecol Oncol2007-10-01T00:00:002007Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer.19172305Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF, Levenback CF, Jhingran A, Parker C, Munsell MF, Smith JASupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerEvaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer. 2009 Sep; 17(9):1195-201.Support Care Cancer2009-01-27T00:00:002009Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment.19264351Schmeler KM, Vadhan-Raj S, Ramirez PT, Apte SM, Cohen L, Bassett RL, Iyer RB, Wolf JK, Levenback CL, Gershenson DM, Freedman RSGynecologic oncologyA phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Gynecol Oncol. 2009 May; 113(2):210-5.Gynecol Oncol2009-03-04T00:00:002009A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.19820377Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyConcurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12.Int J Gynecol Cancer2009-08-01T00:00:002009Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter?20375796Chi DS, Barlin JN, Ramirez PT, Levenback CF, Mironov S, Sarasohn DM, Iyer RB, Dao F, Hricak H, Barakat RRInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyFollow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller. Int J Gynecol Cancer. 2010 Apr; 20(3):353-7.Int J Gynecol Cancer2010-04-01T00:00:002010Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.22927482Moroney J, Fu S, Moulder S, Falchook G, Helgason T, Levenback C, Hong D, Naing A, Wheler J, Kurzrock RClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. Clin Cancer Res. 2012 Oct 15; 18(20):5796-805.Clin Cancer Res2012-08-27T00:00:002012Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity.23332221Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp AInternational journal of radiation oncology, biology, physicsAnatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50.Int J Radiat Oncol Biol Phys2013-01-17T00:00:002013Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.Authorship 2355871Authorship 2379521Authorship 2380981Authorship 2385322Authorship 2387501Authorship 2388705Authorship 2388802Authorship 2389422Authorship 2391534Authorship 2395191Authorship 2396923Authorship 2398714Authorship 2399302Authorship 2401924Authorship 2402875Authorship 2406525Authorship 2413284Authorship 2416034Authorship 2419294Authorship 2426779Authorship 2429071Authorship 2433512Authorship 2437153Authorship 2438819Authorship 2443538Authorship 2446514Authorship 2446822Authorship 2454015Authorship 2456474Authorship 2458697Authorship 2459312Authorship 2461225Authorship 2462792Authorship 2463239Authorship 2490648Authorship 2493725Authorship 2502834Authorship 2508711Authorship 2512361Authorship 2513251Authorship 2514843Authorship 2547323Authorship 2549996Authorship 2550146Authorship 2550841Authorship 2561773Authorship 2566254Authorship 2571533Authorship 2577337Authorship 2578008Authorship 2579766Authorship 25920131526508Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JTGynecologic oncologyUterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992 Sep; 46(3):317-21.Gynecol Oncol1992-09-01T00:00:001992Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).7557603Ripley D, Levenback C, Eifel P, Lewis RMGynecologic oncologyAdenocarcinoma of the cervix in a renal transplant patient. Gynecol Oncol. 1995 Oct; 59(1):151-5.Gynecol Oncol1995-10-01T00:00:001995Adenocarcinoma of the cervix in a renal transplant patient.7590476Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DMGynecologic oncologyPotential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20.Gynecol Oncol1995-11-01T00:00:001995Potential applications of intraoperative lymphatic mapping in vulvar cancer.7622106Miller B, Morris M, Levenback C, Burke TW, Gershenson DMGynecologic oncologyPelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995 Aug; 58(2):202-5.Gynecol Oncol1995-08-01T00:00:001995Pelvic exenteration for primary and recurrent vulvar cancer.7672700Gershenson DM, Morris M, Burke TW, Levenback C, Kavanagh JJ, Fromm GL, Silva EG, Warner D, Wharton JTGynecologic oncologyCombined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol. 1995 Sep; 58(3):349-55.Gynecol Oncol1995-09-01T00:00:001995Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer.7705704Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DMGynecologic oncologyTreatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8.Gynecol Oncol1995-04-01T00:00:001995Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy.7724104Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DMObstetrics and gynecologyOvarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9.Obstet Gynecol1995-05-01T00:00:001995Ovarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy.7896187Miller B, Morris M, Gershenson DM, Levenback CL, Burke TWGynecologic oncologyIntestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990. Gynecol Oncol. 1995 Feb; 56(2):207-10.Gynecol Oncol1995-02-01T00:00:001995Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990.7959265Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, Baker VVGynecologic oncologyPostoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994 Oct; 55(1):47-50.Gynecol Oncol1994-10-01T00:00:001994Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma.7989951Lehman E, Gershenson DM, Burke TW, Levenback C, Silva EG, Morris MJournal of clinical oncology : official journal of the American Society of Clinical OncologySalvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol. 1994 Dec; 12(12):2737-42.J Clin Oncol1994-12-01T00:00:001994Salvage surgery for chemorefractory gestational trophoblastic disease.8041523Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MIObstetrics and gynecologyIntraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994 Aug; 84(2):163-7.Obstet Gynecol1994-08-01T00:00:001994Intraoperative lymphatic mapping for vulvar cancer.8157186Levenback C, Gershenson DM, McGehee R, Eifel PJ, Morris M, Burke TWGynecologic oncologyEnterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300.Gynecol Oncol1994-03-01T00:00:001994Enterovesical fistula following radiotherapy for gynecologic cancer.8630862Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DMCancerInfusion site soft-tissue injury after paclitaxel administration. Cancer. 1995 Jul 01; 76(1):116-20.Cancer1995-07-01T00:00:001995Infusion site soft-tissue injury after paclitaxel administration.8684768Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MFObstetrics and gynecologyAdenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6.Obstet Gynecol1996-07-01T00:00:001996Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.8898166Levenback C, Burke TW, Rubin SC, Curtin JP, Wharton JTGynecologic oncologyArterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol. 1996 Oct; 63(1):40-6.Gynecol Oncol1996-10-01T00:00:001996Arterial occlusion complicating treatment of gynecologic cancer: a case series.8918419Ratliff CR, Gershenson DM, Morris M, Burke TW, Levenback C, Schover LR, Mitchell MF, Atkinson EN, Wharton JTCancerSexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996 Nov 15; 78(10):2229-35.Cancer1996-11-15T00:00:001996Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration.9827720Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos CCancerSerous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer. 1998 Nov 15; 83(10):2157-63.Cancer1998-11-15T00:00:001998Serous borderline tumors of the ovary with noninvasive peritoneal implants.10590370Gershenson DM, Morris M, Burke TW, Levenback C, Wolf J, Lee JJ, Thall PF, Atkinson EN, Silva EG, Wharton JTCancerA phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer. 1999 Dec 01; 86(11):2291-300.Cancer1999-12-01T00:00:001999A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.10831370Levenback C, Coleman RL, Ansink A, van der Zee AGGynecologic oncologyRe: Terada et al.: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76:40-44, 2000. Gynecol Oncol. 2000 Jun; 77(3):484-5.Gynecol Oncol2000-06-01T00:00:002000Re: Terada et al.: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76:40-44, 2000.10907172Vang R, Medeiros LJ, Malpica A, Levenback C, Deavers MInternational journal of gynecological pathology : official journal of the International Society of Gynecological PathologistsNon-Hodgkin's lymphoma involving the vulva. Int J Gynecol Pathol. 2000 Jul; 19(3):236-42.Int J Gynecol Pathol2000-07-01T00:00:002000Non-Hodgkin's lymphoma involving the vulva.11520135Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC, Gajewski JL, Champlin REGynecologic oncologyHigh-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol. 2001 Sep; 82(3):420-6.Gynecol Oncol2001-09-01T00:00:002001High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.11555721Ramirez PT, Levenback CCurrent opinion in oncologySentinel nodes in gynecologic malignancies. Curr Opin Oncol. 2001 Sep; 13(5):403-7.Curr Opin Oncol2001-09-01T00:00:002001Sentinel nodes in gynecologic malignancies.11745287Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, Vincent M, Nelson T, Levenback C, Community Clinical Oncology ProgramCancerPhase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.Cancer2001-11-01T00:00:002001Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.12060455Ramondetta LM, Silva EG, Levenback CF, Burke TWInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyMixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer. 2002 May-Jun; 12(3):312-6.Int J Gynecol Cancer2002-05-01T00:00:002002Mixed choriocarcinoma in a postmenopausal patient.12525521Bodurka DC, Levenback C, Wolf JK, Gano J, Wharton JT, Kavanagh JJ, Gershenson DMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. J Clin Oncol. 2003 Jan 15; 21(2):291-7.J Clin Oncol2003-01-15T00:00:002003Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.12957252Katz A, Eifel PJ, Jhingran A, Levenback CFInternational journal of radiation oncology, biology, physicsThe role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):409-18.Int J Radiat Oncol Biol Phys2003-10-01T00:00:002003The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva.13678720Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus RGynecologic oncologyA phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.Gynecol Oncol2003-09-01T00:00:002003A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets.13678736Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback CGynecologic oncologyGroin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.Gynecol Oncol2003-09-01T00:00:002003Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy.14607039Chung L, Broaddus R, Crozier M, Luthraa R, Levenback C, Lu KObstetrics and gynecologyUnexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer. Obstet Gynecol. 2003 Nov; 102(5 Pt 2):1152-5.Obstet Gynecol2003-11-01T00:00:002003Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer.14766251Schimp VL, Worley C, Brunello S, Levenback CC, Wolf JK, Sun CC, Bodurka DC, Ramirez PTGynecologic oncologyVacuum-assisted closure in the treatment of gynecologic oncology wound failures. Gynecol Oncol. 2004 Feb; 92(2):586-91.Gynecol Oncol2004-02-01T00:00:002004Vacuum-assisted closure in the treatment of gynecologic oncology wound failures.15047210Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJGynecologic oncologySmall cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1):27-33.Gynecol Oncol2004-04-01T00:00:002004Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.15122311Donato ML, Aleman A, Champlin RE, Saliba RM, Wharton JT, Burke TW, Bodurka DC, Bevers MW, Levenback CF, Wolf JK, Bast RC, Freedman RS, Ippoliti C, Brewer M, Gajewski JL, Gershenson DMBone marrow transplantationAnalysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004 Jun; 33(12):1219-24.Bone Marrow Transplant2004-06-01T00:00:002004Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation.15228413Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyRole of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer. 2004 May-Jun; 14(3):399-422.Int J Gynecol Cancer2004-05-01T00:00:002004Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review.15350348Ramirez PT, Levenback CGynecologic oncologyRadical trachelectomy: is it here to stay? Gynecol Oncol. 2004 Sep; 94(3):611-3.Gynecol Oncol2004-09-01T00:00:002004Radical trachelectomy: is it here to stay?16803493Eifel PJ, Jhingran A, Brown J, Levenback C, Thames HInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyTime course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1106-11.Int J Gynecol Cancer2006-05-01T00:00:002006Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix.16803501Maluf FC, Leiser AL, Aghajanian C, Sabbatini P, Pezzulli S, Chi DS, Wolf JK, Levenback C, Loh E, Spriggs DRInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPhase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1165-71.Int J Gynecol Cancer2006-05-01T00:00:002006Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.17292457Crotzer DR, Wolf JK, Gano JB, Gershenson DM, Levenback CGynecologic oncologyA pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary. Gynecol Oncol. 2007 May; 105(2):399-403.Gynecol Oncol2007-02-09T00:00:002007A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.17943389Levenback CFAnnals of surgical oncologyStatus of sentinel lymph node biopsy in gynecological cancers. Ann Surg Oncol. 2008 Jan; 15(1):18-20.Ann Surg Oncol2007-10-18T00:00:002007Status of sentinel lymph node biopsy in gynecological cancers.18281651Levenback CFJournal of clinical oncology : official journal of the American Society of Clinical OncologyHow safe is sentinel lymph node biopsy in patients with vulvar cancer? J Clin Oncol. 2008 Feb 20; 26(6):828-9.J Clin Oncol2008-02-20T00:00:002008How safe is sentinel lymph node biopsy in patients with vulvar cancer?18804266Levenback CGynecologic oncologyUpdate on sentinel lymph node biopsy in gynecologic cancers. Gynecol Oncol. 2008 Nov; 111(2 Suppl):S42-3.Gynecol Oncol2008-09-18T00:00:002008Update on sentinel lymph node biopsy in gynecologic cancers.19258933Eifel PJ, Jhingran A, Levenback CF, Tucker SInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPredictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer. 2009 Jan; 19(1):2-7.Int J Gynecol Cancer2009-01-01T00:00:002009Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter.19933049Cheng X, Moroney JW, Levenback CF, Fu S, Jaishuen A, Kavanagh JJJournal of chemotherapy (Florence, Italy)What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies? J Chemother. 2009 Nov; 21(5):566-72.J Chemother2009-11-01T00:00:002009What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?20466124Levenback CGynecologic oncologyNew or not? Difficulties recognizing innovation. Gynecol Oncol. 2010 Jun; 117(3):399-400.Gynecol Oncol2010-06-01T00:00:002010New or not? Difficulties recognizing innovation.21472713Fu S, Hu W, Iyer R, Kavanagh JJ, Coleman RL, Levenback CF, Sood AK, Wolf JK, Gershenson DM, Markman M, Hennessy BT, Kurzrock R, Bast RCCancerPhase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer. Cancer. 2011 Apr 15; 117(8):1661-9.Cancer2010-11-08T00:00:002010Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.21480244Leong SP, Zuber M, Ferris RL, Kitagawa Y, Cabanas R, Levenback C, Faries M, Saha SJournal of surgical oncologyImpact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol. 2011 May 01; 103(6):518-30.J Surg Oncol2011-05-01T00:00:002011Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.21777966Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun CGynecologic oncologyWork related stress among gynecologic oncologists. Gynecol Oncol. 2011 Nov; 123(2):365-9.Gynecol Oncol2011-07-20T00:00:002011Work related stress among gynecologic oncologists.21804823Markman M, Sehouli J, Levenback CF, Chi DSJournal of oncologyEpithelial ovarian cancer: focus on targeted therapy. J Oncol. 2010; 2010:171425.J Oncol2011-07-05T00:00:002011Epithelial ovarian cancer: focus on targeted therapy.21892091Small W, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven KInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyExtended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer. 2011 Oct; 21(7):1266-75.Int J Gynecol Cancer2011-10-01T00:00:002011Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116.22193645Viswanathan AN, Moughan J, Small W, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DKInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyThe quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer. 2012 Jan; 22(1):123-31.Int J Gynecol Cancer2012-01-01T00:00:002012The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.22487539Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC, Mills GBGynecologic oncologyPerifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol. 2012 Jul; 126(1):47-53.Gynecol Oncol2012-04-06T00:00:002012Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.22813886Cain K, Schmeler KM, Langley G, Max O, Ramirez PT, Levenback CFGynecologic oncologyPatient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer. Gynecol Oncol. 2012 Oct; 127(1):18-21.Gynecol Oncol2012-07-17T00:00:002012Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer.23718934Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BAGynecologic oncologyReporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6.Gynecol Oncol2013-05-26T00:00:002013Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative.25519758Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LMSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerTargeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32.Support Care Cancer2014-12-18T00:00:002014Targeting those with decreased meaning and peace: a supportive care opportunity.Authorship 2634844Authorship 2636693Authorship 2637621Authorship 2642763Authorship 2644563Authorship 2644742Authorship 264698Authorship 2647161Authorship 2647371Authorship 2647482Authorship 2648932Authorship 2660665Authorship 2681975Authorship 2695677Authorship 2700911Authorship 2706554Authorship 2709503Authorship 27232427557615Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DMGynecologic oncologyProlonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6.Gynecol Oncol1995-10-01T00:00:001995Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva.7635768Eifel PJ, Levenback C, Wharton JT, Oswald MJInternational journal of radiation oncology, biology, physicsTime course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995 Jul 30; 32(5):1289-300.Int J Radiat Oncol Biol Phys1995-07-30T00:00:001995Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix.7729737Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DMGynecologic oncologySurgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20.Gynecol Oncol1995-05-01T00:00:001995Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.7789894Crozier M, Morris M, Levenback C, Lucas KR, Atkinson EN, Wharton JTGynecologic oncologyPelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol. 1995 Jul; 58(1):74-8.Gynecol Oncol1995-07-01T00:00:001995Pelvic exenteration for adenocarcinoma of the uterine cervix.7828603Levenback C, Curtin J, Johnston D, Rubin SC, Yeh S, Hoskins WEuropean journal of gynaecological oncologyImage analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancer. Eur J Gynaecol Oncol. 1994; 15(5):345-51.Eur J Gynaecol Oncol1994-01-01T00:00:001994Image analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancer.7970463Burke TW, Morris M, Levenback C, Gershenson DM, Wharton JTObstetrics and gynecologyClosure of complex vulvar defects using local rhomboid flaps. Obstet Gynecol. 1994 Dec; 84(6):1043-7.Obstet Gynecol1994-12-01T00:00:001994Closure of complex vulvar defects using local rhomboid flaps.9586904Brader KR, Morris M, Levenback C, Levy L, Lucas KR, Gershenson DMJournal of clinical oncology : official journal of the American Society of Clinical OncologyChemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol. 1998 May; 16(5):1879-84.J Clin Oncol1998-05-01T00:00:001998Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design.10831367Powell JL, Joseph DBGynecologic oncologyAbdominal sacral colpopexy in patients with gynecologic cancer and "Burch" not "Birch". Gynecol Oncol. 2000 Jun; 77(3):483-4.Gynecol Oncol2000-06-01T00:00:002000Abdominal sacral colpopexy in patients with gynecologic cancer and "Burch" not "Birch".10857169Levenback CRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancerIntraoperative lymphatic mapping and sentinel node identification: gynecologic applications. Recent Results Cancer Res. 2000; 157:150-8.Recent Results Cancer Res2000-01-01T00:00:002000Intraoperative lymphatic mapping and sentinel node identification: gynecologic applications.11193920Verschraegen CF, Levenback C, Vincent M, Wolf J, Bevers M, Loyer E, Kudelka AP, Kavanagh JJAnnals of the New York Academy of SciencesPhase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Ann N Y Acad Sci. 2000; 922:349-51.Ann N Y Acad Sci2000-01-01T00:00:002000Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan.11606084Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DMGynecologic oncologyIntraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001 Nov; 83(2):276-81.Gynecol Oncol2001-11-01T00:00:002001Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer.11641017Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A, Radiation Therapy Oncology GroupInternational journal of radiation oncology, biology, physicsRadiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):58-9.Int J Radiat Oncol Biol Phys2001-01-01T00:00:002001Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group.15738017Sood AK, Cooper BC, Sorosky JI, Ramirez PT, Levenback CObstetrics and gynecologyNovel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation. Obstet Gynecol. 2005 Mar; 105(3):514-8.Obstet Gynecol2005-03-01T00:00:002005Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation.16806436Ramirez PT, Slomovitz BM, McQuinn L, Levenback C, Coleman RLGynecologic oncologyRole of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Gynecol Oncol. 2006 Dec; 103(3):888-90.Gynecol Oncol2006-06-27T00:00:002006Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.18971136Jandial DD, Soliman PT, Slomovitz BM, Schmeler KM, Levenback C, Coleman RL, Ramirez PTJournal of minimally invasive gynecologyLaparoscopic colostomy in gynecologic cancer. J Minim Invasive Gynecol. 2008 Nov-Dec; 15(6):723-8.J Minim Invasive Gynecol2008-11-01T00:00:002008Laparoscopic colostomy in gynecologic cancer.20537951Levenback CFThe Lancet. OncologyHow important is size of sentinel lymph-node metastases in patients with vulvar cancer? Lancet Oncol. 2010 Jul; 11(7):607-8.Lancet Oncol2010-05-25T00:00:002010How important is size of sentinel lymph-node metastases in patients with vulvar cancer?20665499Brown J, Smith JA, Ramondetta LM, Sood AK, Ramirez PT, Coleman RL, Levenback CF, Munsell MF, Jung M, Wolf JKCancerCombination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer. 2010 Nov 01; 116(21):4973-9.Cancer2010-11-01T00:00:002010Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.23201592Coleman RL, Ali S, Levenback CF, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ, Van Le L, Trimble CLGynecologic oncologyIs bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013 Feb; 128(2):155-9.Gynecol Oncol2012-11-29T00:00:002012Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.Authorship 2725352Authorship 2735401Authorship 2736538Authorship 2743455Authorship 2750811Authorship 2762287Authorship 2766881Authorship 2767734Authorship 27723537622103Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DMGynecologic oncologyStaging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93.Gynecol Oncol1995-08-01T00:00:001995Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.8690296Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, Wharton JTGynecologic oncologyGroin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol. 1996 Jul; 62(1):73-7.Gynecol Oncol1996-07-01T00:00:001996Groin dissection practices among gynecologic oncologists treating early vulvar cancer.9740693Morris M, Brader KR, Burke TW, Levenback CF, Gershenson DMGynecologic oncologyA phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8.Gynecol Oncol1998-08-01T00:00:001998A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.11426978Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DMGynecologic oncologyTreatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61.Gynecol Oncol2001-07-01T00:00:002001Treatment of uterine papillary serous carcinoma with paclitaxel.16198958Valbuena JR, Levenback C, Mansfield P, Liu JAnnals of diagnostic pathologyAngiosarcoma of the spleen clinically presenting as metastatic ovarian cancer. A case report and review of the literature. Ann Diagn Pathol. 2005 Oct; 9(5):289-92.Ann Diagn Pathol2005-10-01T00:00:002005Angiosarcoma of the spleen clinically presenting as metastatic ovarian cancer. A case report and review of the literature.17761270Levenback CFGynecologic oncologyStatus of sentinel lymph nodes in cervical cancer. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S18-9.Gynecol Oncol2007-08-29T00:00:002007Status of sentinel lymph nodes in cervical cancer.18457865Ramirez PT, Schmeler KM, Milam MR, Slomovitz BM, Smith JA, Kavanagh JJ, Deavers M, Levenback C, Coleman RL, Gershenson DMGynecologic oncologyEfficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum. Gynecol Oncol. 2008 Jul; 110(1):56-9.Gynecol Oncol2008-05-05T00:00:002008Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.22387451Noguera IR, Sun CC, Broaddus RR, Branham D, Levenback CF, Ramirez PT, Sood AK, Coleman RL, Gershenson DMGynecologic oncologyPhase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube. Gynecol Oncol. 2012 Jun; 125(3):640-5.Gynecol Oncol2012-02-28T00:00:002012Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube.22753905Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ, Van Le L, Trimble CLJournal of clinical oncology : official journal of the American Society of Clinical OncologyLymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012 Nov 01; 30(31):3786-91.J Clin Oncol2012-07-02T00:00:002012Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.Authorship 27867710Authorship 2789675Authorship 2794802Authorship 2889558Authorship 2892604Authorship 2925078Authorship 2941507Authorship 29856110Authorship 30053514Authorship 3025912Authorship 3037895Authorship 3092111Authorship 3093295Authorship 3093493Authorship 3094003Authorship 3107641Authorship 31480567959287Munkarah A, Gershenson DM, Levenback C, Silva EG, Messing MJ, Morris M, Burke TWGynecologic oncologySalvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994 Nov; 55(2):217-23.Gynecol Oncol1994-11-01T00:00:001994Salvage surgery for chemorefractory ovarian germ cell tumors.8022454Levenback CThe New England journal of medicine. . . and how the decisions are made. N Engl J Med. 1994 Aug 04; 331(5):331; author reply 332.N Engl J Med1994-08-04T00:00:001994. . . and how the decisions are made.8188085Morris M, Gershenson DM, Burke TW, Mitchell MF, Levenback C, Atkinson N, Wharton JTGynecologic oncologyA phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8.Gynecol Oncol1994-05-01T00:00:001994A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.8206415Segreti EM, Munkarah A, Levenback CGynecologic oncologySuccessful percutaneous drainage of gluteal pyomyositis occurring after intra-arterial chemotherapy and pelvic irradiation. Gynecol Oncol. 1994 Jun; 53(3):376-9.Gynecol Oncol1994-06-01T00:00:001994Successful percutaneous drainage of gluteal pyomyositis occurring after intra-arterial chemotherapy and pelvic irradiation.9722447Levenback CThe New England journal of medicineShould we accept mediocrity? N Engl J Med. 1998 Aug 27; 339(9):638.N Engl J Med1998-08-27T00:00:001998Should we accept mediocrity?16603073Apte SM, Vadhan-Raj S, Cohen L, Bassett RL, Gordon IO, Levenback CF, Ramirez PT, Gallardo ST, Patenia RS, Garcia ME, Iyer RB, Freedman RSJournal of translational medicineCytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. J Transl Med. 2006 Apr 07; 4:16.J Transl Med2006-04-07T00:00:002006Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.24674263Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJPractical radiation oncologyAnatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):45-53.Pract Radiat Oncol2012-03-30T00:00:002012Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer.24742900Piha-Paul SA, Wheler JJ, Fu S, Levenback C, Lu K, Falchook GS, Naing A, Hong DS, Tsimberidou AM, Kurzrock ROncotargetAdvanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus. Oncotarget. 2014 Apr 15; 5(7):1846-55.Oncotarget2014-04-15T00:00:002014Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus.25451693Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DCGynecologic oncologyPerioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol. 2015 Jan; 136(1):65-70.Gynecol Oncol2014-11-14T00:00:002014Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database.25624430Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RLJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma. J Clin Oncol. 2015 Mar 10; 33(8):930-6.J Clin Oncol2015-01-26T00:00:002015Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.26022527Slomovitz BM, Coleman RL, Oonk MH, van der Zee A, Levenback CGynecologic oncologyUpdate on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol. 2015 Aug; 138(2):472-7.Gynecol Oncol2015-05-27T00:00:002015Update on sentinel lymph node biopsy for early-stage vulvar cancer.26240233Wright AA, Cronin A, Milne DE, Bookman MA, Burger RA, Cohn DE, Cristea MC, Griggs JJ, Keating NL, Levenback CF, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland JC, Weeks JC, O'Malley DMJournal of clinical oncology : official journal of the American Society of Clinical OncologyUse and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2015 Sep 10; 33(26):2841-7.J Clin Oncol2015-08-03T00:00:002015Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.26549108Prescott LS, Dickens AS, Guerra SL, Tanha JM, Phillips DG, Patel KT, Umberson KM, Lozano MA, Lowe KB, Brown AJ, Taylor JS, Soliman PT, Garcia EA, Levenback CF, Bodurka DCGynecologic oncologyFighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol. 2016 Jan; 140(1):114-9.Gynecol Oncol2015-11-05T00:00:002015Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education.26724493Ramirez PT, Levenback CGynecologic oncologyLong-term outcomes of sentinel node mapping in vulvar cancer: A time to cheer with enthusiasm or pause and question current practice? Gynecol Oncol. 2016 Jan; 140(1):1-2.Gynecol Oncol2016-01-01T00:00:002016Long-term outcomes of sentinel node mapping in vulvar cancer: A time to cheer with enthusiasm or pause and question current practice?15571612Ramirez PT, Frumovitz M, Wolf JK, Levenback CInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyLaparoscopic port-site metastases in patients with gynecological malignancies. Int J Gynecol Cancer. 2004 Nov-Dec; 14(6):1070-7.Int J Gynecol Cancer2004-11-01T00:00:002004Laparoscopic port-site metastases in patients with gynecological malignancies.74Professor14Associate ProfessorBreast Surgical Oncology15850914Frank SJ, Jhingran A, Levenback C, Eifel PJInternational journal of radiation oncology, biology, physicsDefinitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005 May 01; 62(1):138-47.Int J Radiat Oncol Biol Phys2005-05-01T00:00:002005Definitive radiation therapy for squamous cell carcinoma of the vagina.11641022Ginsburg R, Bullard D, Eisenberg B, Gomella L, Johnstone D, Pisters PW, Sigurdson E, Weber R, Levenback C, Radiation Therapy Oncology GroupInternational journal of radiation oncology, biology, physicsRadiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):92-5.Int J Radiat Oncol Biol Phys2001-01-01T00:00:002001Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee.16234510Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DCJournal of clinical oncology : official journal of the American Society of Clinical OncologyQuality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.J Clin Oncol2005-10-20T00:00:002005Quality of life and sexual functioning in cervical cancer survivors.16483643Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback CGynecologic oncologyElectrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol. 2006 Sep; 102(3):534-6.Gynecol Oncol2006-02-17T00:00:002006Electrothermal bipolar coagulation for pelvic exenterations.16580331Frumovitz M, Coleman RL, Gayed IW, Ramirez PT, Wolf JK, Gershenson DM, Levenback CFAmerican journal of obstetrics and gynecologyUsefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol. 2006 Apr; 194(4):1186-93; discussion 1193-5.Am J Obstet Gynecol2006-04-01T00:00:002006Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer.16687095Coleman RL, Frumovitz M, Levenback CFJournal of the National Comprehensive Cancer Network : JNCCNCurrent perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix. J Natl Compr Canc Netw. 2006 May; 4(5):471-8.J Natl Compr Canc Netw2006-05-01T00:00:002006Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix.15350368Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf J, Bodurka DC, Levenback CGynecologic oncologyLaparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol. 2004 Sep; 94(3):746-53.Gynecol Oncol2004-09-01T00:00:002004Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training.18722970Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, Ramirez PTJournal of minimally invasive gynecologyA phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.J Minim Invasive Gynecol2008-09-01T00:00:002008A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer.14603539Follen M, Levenback CF, Iyer RB, Grigsby PW, Boss EA, Delpassand ES, Fornage BD, Fishman EKCancerImaging in cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2028-38.Cancer2003-11-01T00:00:002003Imaging in cervical cancer.15385122Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback CGynecologic oncologyHormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004 Oct; 95(1):133-8.Gynecol Oncol2004-10-01T00:00:002004Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.22240566Worley MJ, Anwandter C, Sun CC, dos Reis R, Nick AM, Frumovitz M, Soliman PT, Schmeler KM, Levenback CF, Munsell MF, Ramirez PTGynecologic oncologyImpact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4.Gynecol Oncol2012-01-10T00:00:002012Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery.22910691Frumovitz M, Euscher ED, Deavers MT, Soliman PT, Schmeler KM, Ramirez PT, Levenback CFGynecologic oncology"Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.Gynecol Oncol2012-08-19T00:00:002012"Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer.17692091Ramirez PT, Frumovitz M, Dos Reis R, Milam MR, Bevers MW, Levenback CF, Coleman RLInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyModified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy. Int J Gynecol Cancer. 2008 May-Jun; 18(3):571-5.Int J Gynecol Cancer2007-08-10T00:00:002007Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy.16963111Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CFGynecologic oncologyLymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3.Gynecol Oncol2006-09-11T00:00:002006Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.17035002Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback CSurgical oncologyRetroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.Surg Oncol2006-10-10T00:00:002006Retroperitoneal lymph node resection in patients with cervical cancer.18473144Frumovitz M, Levenback CFAnnals of surgical oncologyIs lymphatic mapping in uterine cancer feasible? Ann Surg Oncol. 2008 Jul; 15(7):1815-7.Ann Surg Oncol2008-05-13T00:00:002008Is lymphatic mapping in uterine cancer feasible?18502488Frumovitz M, Ramirez PT, Levenback CFGynecologic oncologyLymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S17-20.Gynecol Oncol2008-05-27T00:00:002008Lymphatic mapping and sentinel lymph node detection in women with cervical cancer.18190952Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CFGynecologic oncologyLymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008 Mar; 108(3):478-81.Gynecol Oncol2008-01-10T00:00:002008Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer.18670356Euscher ED, Malpica A, Atkinson EN, Levenback CF, Frumovitz M, Deavers MTThe American journal of surgical pathologyUltrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol. 2008 Sep; 32(9):1336-43.Am J Surg Pathol2008-09-01T00:00:002008Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma.19546764Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Dos Reis R, Levenback CF, Ramirez PTObstetrics and gynecologyParametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-99.Obstet Gynecol2009-07-01T00:00:002009Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.20139817Kobayashi K, Ramirez PT, Kim EE, Levenback CF, Rohren EM, Frumovitz M, Mar MV, Gayed IWClinical nuclear medicineSentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med. 2009 Dec; 34(12):859-61.Clin Nucl Med2009-12-01T00:00:002009Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy.21872911Soliman PT, Frumovitz M, Sun CC, Dos Reis R, Schmeler KM, Nick AM, Westin SN, Brown J, Levenback CF, Ramirez PTGynecologic oncologyRadical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.Gynecol Oncol2011-08-27T00:00:002011Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology.21099603Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PTObstetrics and gynecologyPrimary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365.Obstet Gynecol2010-12-01T00:00:002010Primary malignant melanoma of the vagina.Authorship 841091Authorship 841446Authorship 841697Authorship 842930Authorship 843591Authorship 843916Authorship 845085Authorship 845402Authorship 846549Authorship 846666Authorship 848213Authorship 849596Authorship 855345Authorship 855513Authorship 857393Authorship 858282Authorship 863248Authorship 863406Authorship 865695Cancer MedicineSurvival of patients with metastatic leiomyosarcoma. Cancer Medicine. 5:3437-3444.Survival of patients with metastatic leiomyosarcomaLymphatic Mapping of the Female Genital Tract. 649-663.Lymphatic Mapping of the Female Genital TractJournal of Gynecologic Oncology NursingCollaborative relationship building top ten strategies to engage physicians. Journal of Gynecologic Oncology Nursing. 19:31-35.Collaborative relationship building top ten strategies to engage physiciansPractical Radiation OncologyAnatomic distribution of [<sup>18</sup>F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Practical Radiation Oncology. 3:45-53.Anatomic distribution of [<sup>18</sup>F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancerGynecologic Oncology4th International Conference on Cervical Cancer. Gynecologic Oncology. 99.4th International Conference on Cervical CancerObstetrical and Gynecological SurveyVenous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Obstetrical and Gynecological Survey. 68:439-440.Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignanciesAnnals of Surgical OncologyThe DISINFECT Initiative. Annals of Surgical Oncology. 1-7.The DISINFECT InitiativeJournal of Oncology PracticeWhat is the real rate of surgical site infection?. Journal of Oncology Practice. 12:e878-e883.What is the real rate of surgical site infection?Journal of Hematology and OncologySTUMP un"stumped". Journal of Hematology and Oncology. 8.STUMP un"stumped"Clinical Consultations in Obstetrics and GynecologyComplications of radiotherapy for treatment of cervix cancer. Clinical Consultations in Obstetrics and Gynecology. 7:152-159.Complications of radiotherapy for treatment of cervix cancerGynecologic OncologyFighting cancer together. Gynecologic Oncology. 140:114-119.Fighting cancer togetherGynecologic malignancy. 447-452.Gynecologic malignancyWomen's Oncology ReviewPelvic irradiation with concurrent chemotherapy versus pelvic for high-risk cervical cancer. Women's Oncology Review. 4:127-128.Pelvic irradiation with concurrent chemotherapy versus pelvic for high-risk cervical cancerVulva. 524-544.VulvaJournal of Translational MedicineCytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. Journal of Translational Medicine. 4.Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinObstetrical and Gynecological SurveyUse of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer. Obstetrical and Gynecological Survey. 71:660-661.Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancerACOG Current Journal ReviewIntraoperative lymphatic mapping for vulvar cancer. ACOG Current Journal Review. 8:41.Intraoperative lymphatic mapping for vulvar cancerCervical cancer. 97-107.Cervical cancerJournal of Clinical OncologyUse and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer. Journal of Clinical Oncology. 34:3854-3863.Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer23200912Schmeler KM, Wilson GL, Cain K, Munsell MF, Ramirez PT, Soliman PT, Nick AM, Frumovitz M, Coleman RL, Kroll MH, Levenback CFGynecologic oncologyVenous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8.Gynecol Oncol2012-11-28T00:00:002012Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.14751159Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback CGynecologic oncologyCharacteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.Gynecol Oncol2004-01-01T00:00:002004Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer.16221380Frumovitz M, Ramirez PT, Levenback CCurrent oncology reportsLymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract. Curr Oncol Rep. 2005 Nov; 7(6):435-43.Curr Oncol Rep2005-11-01T00:00:002005Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract.18533402Frumovitz M, Levenback CFOncology (Williston Park, N.Y.)Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers. Oncology (Williston Park). 2008 Apr 30; 22(5):529-36; discussion 538-9, 542-3.Oncology (Williston Park)2008-04-30T00:00:002008Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers.20708226Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LMGynecologic oncologyLymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4.Gynecol Oncol2010-08-12T00:00:002010Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists.22668880Zand B, Frumovitz M, Jofre MF, Nick AM, Dos Reis R, Munsell MF, Sangi-Haghpeykar H, Levenback C, Soliman PT, Schmeler KM, Ramirez PTGynecologic oncologyRisk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gynecol Oncol. 2012 Sep; 126(3):428-31.Gynecol Oncol2012-06-02T00:00:002012Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery.D005833Disorders1887340.597691Genital Neoplasms, FemaleD021701Procedures22114080.580974Sentinel Lymph Node BiopsyD008198Anatomy68229540.450594Lymph NodesD014846Disorders932390.833202Vulvar NeoplasmsAuthorship 9048899Authorship 90491720Authorship 90774512Authorship 9080448Authorship 9169949Authorship 9180683Authorship 92228510Authorship 9272668Authorship 936721427460495Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KMJournal of oncology practiceWhat Is the Real Rate of Surgical Site Infection? J Oncol Pract. 2016 10; 12(10):e878-e883.J Oncol Pract2016-10-01T00:00:002016What Is the Real Rate of Surgical Site Infection?27442965Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AAJAMA oncologyUse of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncol. 2016 Nov 01; 2(11):1427-1433.JAMA Oncol2016-11-01T00:00:002016Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.27573526Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KMAnnals of surgical oncologyThe DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol. 2017 Feb; 24(2):362-368.Ann Surg Oncol2016-08-29T00:00:002016The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology.27882721Wang Z, Shi N, Naing A, Janku F, Subbiah V, Araujo DM, Patel SR, Ludwig JA, Ramondetta LM, Levenback CF, Ramirez PT, Piha-Paul SA, Hong D, Karp DD, Tsimberidou AM, Meric-Bernstam F, Fu SCancer medicineSurvival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience. Cancer Med. 2016 12; 5(12):3437-3444.Cancer Med2016-11-23T00:00:002016Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience.27864417Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto VG, Tetzlaff MTClinical cancer research : an official journal of the American Association for Cancer ResearchTumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104.Clin Cancer Res2016-11-18T00:00:002016Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.28188015Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, Frumovitz MGynecologic oncologySensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.Gynecol Oncol2017-02-08T00:00:002017Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.27601552Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyUse and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 11 10; 34(32):3854-3863.J Clin Oncol2016-11-10T00:00:002016Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.28528918Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KHGynecologic oncologyA prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239.Gynecol Oncol2017-05-18T00:00:002017A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.30519622Slomovitz BM, Taub MC, Huang M, Levenback C, Coleman RLGynecologic oncology reportsA randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS). Gynecol Oncol Rep. 2019 Feb; 27:1-4.Gynecol Oncol Rep2018-11-16T00:00:002018A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS).D002583Disorders34218410.444924Uterine Cervical NeoplasmsAuthorship 941496830872025Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KMGynecologic oncologyChoosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol. 2019 06; 153(3):597-603.Gynecol Oncol2019-03-11T00:00:002019Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology.Authorship 944831730946086Marcus RK, Lillemoe HA, Caudle AS, Weinberg JS, Gidley PW, Skibber JM, Levenback CF, Swisher SG, Aloia TAAnnals of surgeryFacilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety? Ann Surg. 2019 12; 270(6):937-941.Ann Surg2019-12-01T00:00:002019Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety?20683399Bhosale P, Peungjesada S, Wei W, Levenback CF, Schmeler K, Rohren E, Macapinlac HA, Iyer RBInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyClinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):936-44.Int J Gynecol Cancer2010-08-01T00:00:002010Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.Authorship 953106931371099Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TAJoint Commission journal on quality and patient safetyPostoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf. 2019 10; 45(10):686-693.Jt Comm J Qual Patient Saf2019-07-29T00:00:002019Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates.33037105Chelariu-Raicu A, Levenback CF, Slomovitz BM, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson DM, Coleman RLInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPhase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. Int J Gynecol Cancer. 2020 11; 30(11):1768-1774.Int J Gynecol Cancer2020-10-09T00:00:002020Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.Authorship 10023942Authorship 10045571433154095Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AKInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyCorrelation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer. 2021 01; 31(1):92-97.Int J Gynecol Cancer2020-11-05T00:00:002020Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.Authorship 1014437133758038Levenback CFInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietySafety, standardization, and surgical innovation: lessons from the development of sentinel node biopsy in gynecologic oncology. Int J Gynecol Cancer. 2021 05; 31(5):656-657.Int J Gynecol Cancer2021-03-23T00:00:002021Safety, standardization, and surgical innovation: lessons from the development of sentinel node biopsy in gynecologic oncology.Authorship 10283402934432481Oonk MHM, Slomovitz B, Baldwin PJW, van Doorn HC, van der Velden J, de Hullu JA, Gaarenstroom KN, Slangen BFM, Vergote I, Br?nnstr?m M, van Dorst EBL, van Driel WJ, Hermans RH, Nunns D, Widschwendter M, Nugent D, Holland CM, Sharma A, DiSilvestro PA, Mannel R, Boll D, Cibula D, Covens A, Provencher D, Runnebaum IB, Luesley D, Ellis P, Duncan TJ, Tjiong MY, Cruickshank DJ, Kj?lhede P, Levenback CF, Bouda J, Kieser KE, Palle C, Spirtos NM, O'Malley DM, Leitao MM, Geller MA, Dhar K, Asher V, Tamussino K, Tobias DH, Borgfeldt C, Lea JS, Bailey J, Lood M, Eyjolfsdottir B, Attard-Montalto S, Tewari KS, Manchanda R, Jensen PT, Persson P, Van Le L, Putter H, de Bock GH, Monk BJ, Creutzberg CL, van der Zee AGJJournal of clinical oncology : official journal of the American Society of Clinical OncologyRadiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II. J Clin Oncol. 2021 11 10; 39(32):3623-3632.J Clin Oncol2021-08-25T00:00:002021Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor24291694Frumovitz M, Coleman RC, Soliman PT, Ramirez PT, Levenback CFGynecologic oncologyA case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9.Gynecol Oncol2013-12-01T00:00:002013A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma.24407177Holman LL, Levenback CF, Frumovitz MJournal of minimally invasive gynecologySentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5.J Minim Invasive Gynecol2014-01-07T00:00:002014Sentinel lymph node evaluation in women with cervical cancer.